Kenneth Galbraith
Chair & CEO at Zymeworks Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Zymeworks Inc., 3 years.
Zymeworks Inc.
Director · Chair & CEO
Chief executive roles
Zymeworks Inc.
· Chair & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 8, 2024 | Zymeworks Inc. | Open-market sale | −5,706 | $11.22 | $64,021 |
| Jan 5, 2024 | Zymeworks Inc. | Option exercise | +47,666 | — | — |
| Jan 5, 2024 | Zymeworks Inc. | Open-market sale | −18,198 | $10.65 | $193,809 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.